IDGXF (IDGXF) Stock Price & Analysis
IDGXF (IDGXF) rose 0.00% to USD 0.49 as of July 25, 2026 at 13:06 UTC, according to Nexqual real-time market data.
IDGXF last closed at USD 0.49; the session ranged USD 0.51–0.51 on volume of 650 shares. Market capitalization is $287.58M, with a 52-week range of USD 0.32–0.7 (PNK). Source: Nexqual, July 25, 2026 at 13:06 UTC.
Key Statistics (as of July 25, 2026 at 13:06 UTC)
| Price | USD 0.49 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.49 |
| Open | USD 0.51 |
| Day Range | USD 0.51 – 0.51 |
| 52-Week Range | USD 0.32 – 0.7 |
| Volume | 650 shares |
| Market Cap | $287.58M |
| Exchange | PNK |
Technical Analysis (IDGXF)
Nexqual's technical model rates IDGXF "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 13:06 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 0.55) |
| MACD | -0.02 (negative) |
Analyst Ratings (IDGXF)
Wall Street analysts rate IDGXF "None", per Nexqual as of July 25, 2026 at 13:06 UTC.
| Consensus Rating | None |
|---|
Earnings (IDGXF)
Source: Nexqual, July 25, 2026 at 13:06 UTC.
Financials & Fundamentals (IDGXF)
| Revenue Growth (YoY) | +31.00% |
|---|---|
| Gross Margin | +42.29% |
| Operating Margin | +0.00% |
| Profit Margin | +17.42% |
| Debt / Equity | 39.06 |
Source: Nexqual, July 25, 2026 at 13:06 UTC.
Financial Health Score (IDGXF)
Nexqual rates IDGXF's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 13:06 UTC.
| Growth | Strong — Revenue +37% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 42%, operating 0% |
| Balance Sheet | Solid — Debt/Equity 0.4x |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (IDGXF)
| Insider Ownership | +62.15% |
|---|---|
| Institutional Ownership | +41.53% |
| Shares Outstanding | 581.33M |
| Float | 165.82M |
Source: Nexqual, July 25, 2026 at 13:06 UTC.
Leadership (IDGXF)
IDGXF is led by Hend El Sherbini (age 56), Group CEO & Executive Director, per Nexqual as of July 25, 2026 at 13:06 UTC.
| Group CEO & Executive Director | Hend El Sherbini (age 56) |
|---|---|
| VP, Group CFO & Executive Director | Sherif Mohamed Mohamed El Zeiny |
| Director of Investor Relations | Tarek Yehia |
Major Backers & Investors (IDGXF)
Notable institutional backers of IDGXF include Fidelity, DFA INVESTMENT TRUST CO-The United Kingdom Small Company Series, according to Nexqual as of July 25, 2026 at 13:06 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 3.39% |
| DFA INVESTMENT TRUST CO-The United Kingdom Small Company Series | 0.21% |
Source: Nexqual, July 25, 2026 at 13:06 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FAMDF | Futura Medical Plc | USD 0.02 | ▲ 76.64% |
| TSUSF | Tsuruha Holdings, Inc. | USD 17.25 | ▲ 0% |
| SRBCF | Sirona Biochem Corp. | USD 0.01 | ▲ 0% |
| RASP | ACTAVIA LIFE SCIENCES INC | USD 0 | ▲ 0% |
| NSTM | NovelStem International Corp. | USD 0.01 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:06 UTC. This page is informational and not investment advice.